Letrozole in assisted reproductive techniques protocol

The effect of adding letrozole to gonadotropin on pregnancy outcomes in patients who are the candidate for assisted reproductive techniques

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20110509006420N19

Enrollment

100

Registered

2018-09-18

Start date

2018-08-01

Completion date

Unknown

Last updated

2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

female Infertility. Female infertility, unspecified

Interventions

Intervention 1: Control group: Antagonist group: since the second day of the cycle all patients Will receive 150 unit of cinal f(cinagen-Iran) Subcutaneously When dominant follicle reached to 12-13 m

Eligibility

Sex/Gender

Female

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Patients referred to the Infertility Center, which is undergoing ovulation induction for assisted reproductive techniques. normal ovarian reserve

Exclusion criteria

Exclusion criteria: History of endocrine disorders Intrauterine abnormality (uterine polyp & sub mucosal fibroma & intrauterine adhesions) Azoospermia of partner Severe endometriosis

Design outcomes

Primary

Measure	Time frame
Chemical pregnancy. Timepoint: 15 days after embryo transfer. Method of measurement: Blood laboratory kit.;Clinical pregnancy. Timepoint: 3 weeks after positive beta-h Cg. Method of measurement: Observation of fetal heart activity by transvaginal ultrasonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Eftekhar

Yazd University of Medical Sciences

eftekharmaryam@yahoo.com+98 35 3824 7085

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026